Yasons Chemex Care subsidiary sale set at Rs 29.61 crore

Yasons Chemex Care Limited disclosed that its 99%-owned subsidiary Rishit Polysurf LLP executed a November 6, 2026 agreement to sell its chemical manufacturing business for Rs 29.61 crore in cash. The agreement transfers the operation as a going concern on a slump-sale basis to Vasudha Specialities Emulsifiers Limited, subject to the Business Transfer Agreement’s terms.

What business is Yasons Chemex Care selling?

Yasons Chemex Care is selling Rishit’s chemical manufacturing business, not its 99% interest in Rishit itself. The Business Transfer Agreement, or BTA, dated November 6, 2026, describes the transaction as a transfer of that business as a going concern on a slump-sale basis. The filing does not provide revenue, profit, asset, capacity or employee figures for the transferred operation.

The transaction covers the entire identified chemical manufacturing business for one cash amount of Rs 29.61 crore. This differs from a sale of separately priced assets because the disclosure does not split the consideration between plant, inventory, working capital, products or intangible assets. Yasons Chemex Care’s corporate description refers to perfumes, deodorants, dyestuff and chemical trading, while the BTA specifically identifies Rishit’s chemical manufacturing business as the transferred activity.

Who is buying the Rishit chemical manufacturing business?

Vasudha Specialities Emulsifiers Limited is buying Rishit’s chemical manufacturing business under the BTA executed on November 6, 2026. The filing describes Vasudha Specialities Emulsifiers as a company incorporated under the Companies Act, 2013, with Corporate Identification Number U20116MR2026PLC480892 and a registered office in Thane, India.

Yasons Chemex Care reported nil shareholding in Vasudha Specialities Emulsifiers, compared with its 99% capital contribution and profit-sharing ratio in Rishit. The company also said the buyer is not related to its promoter, promoter group or group companies, and that the transaction is not a related-party transaction. This separates the buyer from the subsidiary ownership structure disclosed for Rishit.

The November 6 announcement gives no turnover, profitability, financing or product information for Vasudha Specialities Emulsifiers. It also records no nominee on Yasons Chemex Care’s board and no potential conflict of interest arising from the agreement. The annexure lists “None” for these other agreement-related disclosures.

How is the Rs 29.61 crore sale structured?

The Rs 29.61 crore consideration is a single lump-sum cash payment for the entire business. The disclosure says no shares are being issued in connection with the sale, marking share-issue details as not applicable and specifying cash consideration as the payment term.

The BTA is a business transfer rather than a disclosed merger, equity subscription or sale of Rishit partnership interests. Its purpose is the sale and transfer of Rishit’s chemical manufacturing business as a going concern, subject to the agreement’s terms and conditions. The filing does not disclose instalments, escrow, adjustments, taxes, conditions precedent or a scheduled completion date.

The lump-sum form means that asset-level values cannot be calculated from the November 6 filing. No allocation is provided for fixed assets, inventories, working capital, brands, customer relationships or individual chemical products. Likewise, the disclosure contains no figures from which to measure a price-to-sales ratio or a gain or loss on the transfer.

What does the filing say about Yasons Chemex Care’s position after the agreement?

Yasons Chemex Care remains the 99% holder of Rishit’s capital contribution and profit-sharing ratio, while Rishit has agreed to transfer its chemical manufacturing business for Rs 29.61 crore. The announced change is therefore the proposed disposal of a subsidiary’s operating business, rather than the disclosed sale of the subsidiary itself.

The filing confirms agreement execution on November 6, 2026, but does not state that the transfer has closed. It says the sale is subject to the BTA’s terms and conditions, without identifying approvals, consents or other closing requirements. No before-and-after financial comparison is available because the announcement contains no historical financial data for Rishit or the business being sold.

Yasons Chemex Care also does not state how the Rs 29.61 crore will be used, whether Rishit will retain other activities, or what accounting effect the transaction may have. The company noted that, as an SME-listed entity, specified corporate-governance provisions do not apply under Regulation 15(2) of the Securities and Exchange Board of India listing regulations. That disclosure does not add financial information on the sale.

Conclusion

Yasons Chemex Care has announced a defined cash disposal through its 99%-owned subsidiary: Rishit agreed to sell its chemical manufacturing business to Vasudha Specialities Emulsifiers for Rs 29.61 crore. The transaction is structured as a single-price slump sale of a going concern, and the company has identified the buyer as unrelated.

The next disclosed milestone is completion under the BTA, since the November 6, 2026 filing says the transfer remains subject to its terms and conditions. Investors should watch for any later disclosure on closing, the use of the Rs 29.61 crore cash consideration, Rishit’s remaining operations and the accounting impact on Yasons Chemex Care.